Get the Stockscreener App
2.57
0.00%
0.00
After Hours:
2.49
-0.08
-3.11%
Alector Inc stock is traded at $2.57, with a volume of 470.64K.
It is up +0.00% in the last 24 hours and up +9.59% over the past month.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
See More
Previous Close:
$2.57
Open:
$2.58
24h Volume:
470.64K
Relative Volume:
0.63
Market Cap:
$285.33M
Revenue:
$21.05M
Net Income/Loss:
$-142.93M
P/E Ratio:
-1.8496
EPS:
-1.3895
Net Cash Flow:
$-184.07M
1W Performance:
+11.74%
1M Performance:
+9.59%
6M Performance:
+97.69%
1Y Performance:
+144.76%
1-Day Range:
$2.565
$2.70
1-Week Range:
$2.15
$2.70
52-Week Range:
$0.9728
$3.3999
Alector Inc Stock (ALEC) Company Profile
Name
Alector Inc
Sector
Industry
Phone
415-231-5660
Address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Compare ALEC vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
2.57 | 285.33M | 21.05M | -142.93M | -184.07M | -1.3895 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-26 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Mar-10-26 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-22-25 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-22-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-22-25 | Downgrade | Mizuho | Outperform → Neutral |
| Oct-22-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-28-25 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-17-24 | Downgrade | Mizuho | Outperform → Neutral |
| Dec-16-24 | Downgrade | Stifel | Buy → Hold |
| Dec-04-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Nov-29-24 | Reiterated | H.C. Wainwright | Buy |
| Nov-26-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-14-23 | Upgrade | Stifel | Hold → Buy |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Sep-25-23 | Initiated | Goldman | Sell |
| Sep-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-13-22 | Initiated | Goldman | Sell |
| Mar-08-22 | Downgrade | Stifel | Buy → Hold |
| Sep-27-21 | Initiated | William Blair | Outperform |
| Jan-15-21 | Resumed | BofA Securities | Buy |
| Jun-24-20 | Initiated | H.C. Wainwright | Buy |
| Apr-28-20 | Initiated | Goldman | Buy |
| Mar-06-20 | Initiated | Citigroup | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Feb-19-20 | Initiated | Stifel | Buy |
| Nov-21-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | Barclays | Overweight |
| Mar-04-19 | Initiated | BofA/Merrill | Buy |
| Mar-04-19 | Initiated | Morgan Stanley | Overweight |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
View All
Alector Inc Stock (ALEC) Latest News
Transcript : Alector, Inc.Special Call - marketscreener.com
MSN Money - MSN
Five-Way Obesity Drug Shows Effectiveness in Mice; Alector Stops Alzheimer’s Trial - geneonline.com
Morgan Stanley raises Alector stock price target on pipeline focus By Investing.com - Investing.com South Africa
Morgan Stanley raises Alector stock price target on pipeline focus - Investing.com
Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Alector (ALEC) - The Globe and Mail
Failure of GSK-partnered Alzheimer’s drug a fresh setback for Alector - The Pharma Letter
Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC) and Alector (ALEC) - The Globe and Mail
Peninsula biotech Alector loses another Alzheimer's battle, shifts to earlier-stage programs - The Business Journals
Alector drops GSK-partnered Alzheimer’s drug (ALEC:NASDAQ) - Seeking Alpha
How The Alector (ALEC) Narrative Is Shifting Toward BBB Shuttle Programs And Execution Risk - Yahoo Finance
GSK-partnered Alector hit with third neuro failure as Alzheimer’s asset disappoints - BioSpace
5AM Venture Management, LLC's Alector Inc(ALEC) Holding History - GuruFocus
[EFFECT] Alector, Inc. SEC Filing - Stock Titan
Biopharmaceutical company Alector Inc. announced that it will discontinue its Phase II PROGRESS-AD clinical trial of its candidate drug Nivisnebart (development code AL101/GSK4527226) for the treatment of early-stage Alzheimer's disease. - Bitget
Alector to discontinue phase 2 trial of nivisnebart - marketscreener.com
Alzheimer’s drug study stops early after review finds low odds of success - Stock Titan
Cantor Fitzgerald upgrades Alector (ALEC) - MSN
Alector (NASDAQ: ALEC) sets 2026 virtual meeting on directors, auditor and say-on-pay - Stock Titan
BlackRock (ALEC) discloses 5.2% ownership of Alector common stock - Stock Titan
Alector gains as Cantor Fitzgerald upgrades on brain carrier platform - MSN
Alector (ALEC)'s technical outlook is bright after key golden cross - MSN
Alector (ALEC) Price Target Decreased by 42.61% to 2.24 - MSN
Alector upgraded at Mizuho on high risk/higher-reward - MSN
Alector (ALEC) Stock: Future Performance Expectations (Buying Pressure) 2026-04-20Elite Alerts - UBND thành phố Hải Phòng
Alector (ALEC) Stock: Why It Matters Now (Trades Higher) 2026-04-20Bearish Pattern - Xã Thanh Hà
Insider Sell: Grace Wong-sarad Sells Shares of Alector Inc (ALEC) - GuruFocus
Alector Inc: Principal accounting officer Wong-Sarad sells $4823 in stock - Investing.com India
Alector Inc: Principal accounting officer Wong-Sarad sells $4823 in stock By Investing.com - Investing.com South Africa
Alector (ALEC) accounting officer sells 1,820 shares in 10b5-1 trade - Stock Titan
ALEC (NASDAQ: ALEC) affiliate reports multiple common-stock sales in Mar 2026 - Stock Titan
This Cloudflare Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday - Benzinga
Alector stock upgraded at Cantor Fitzgerald (ALEC:NASDAQ) - Seeking Alpha
ALEC Upgraded by Cantor Fitzgerald -- Rating Raised to Overweigh - GuruFocus
Cantor Fitzgerald Upgrades Alector (NASDAQ:ALEC) to "Overweight" - MarketBeat
Alector Inc Stock (ALEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.77%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):